A hereditary component is implicated in many different cancers, including hairy cell leukemia (HCL), and may involve an instability of the genome. We have previously documented recurrent clonal and non-clonal chromosomal abnormalities in hairy cells. To ascertain whether this instability of the genome is restricted to the malignant cells or if it might also include normal cells we performed cytogenetic investigations on skin fibroblasts and hairy cells from eight HCL patients and skin fibroblasts from eight referents. The frequency of chromosome abnormalities, regardless of clonality, was significantly increased in the fibroblasts from patients compared to referents. Also, five patients compared to one referent showed clonal abnormalities in their fibroblasts. Immunohistochemical investigations excluded the possibility that the fibroblast cultures were contaminated with hairy cells. Two patients had constitutional abnormalities, inv(5)(p13.1q13.3) and t(13;14), and one additional patient, possibly mosaic, showed the same abnormality, inv (9) 
Introduction
Genomic instability, which promotes the accumulation of genetic changes, has been implicated as an initial step in the formation of a neoplastic clonal cell population, 1 with more complex abnormalities occurring during tumor progression. A number of mechanisms has been implicated, such as defects in mismatch repair leading to microsatellite instability associated with mutations in TGF-␤ receptor genes, 2 and abnormalities of mitotic checkpoints allowing cells to proceed through the cell cycle without previous repair of DNA damage. 3 Karyotype instability, however, does not seem to be restricted to neoplastic tissues only. A general increase of chromosome abnormalities in peripheral blood lymphocytes predicts an increased cancer risk. This is shown by an ongoing prospective cohort study of the Nordic study group on the health risk of chromosome damage 4 and by an Italian cohort study. 5 Also, in a prospective study of myelodysplasia it was shown that karyotype instability preceded clonal development. 6 An overall increase in stable and unstable aberrations, including chromatid and chromosome breaks, has been noted in lymphocytes from patients with malignant diseases, eg myelodysplasia and colorectal cancer, in unaffected skin from patients with neurofibromatosis 1, and in predisposing conditions, such as celiac disease. [7] [8] [9] [10] On the other hand, in non-malignant cells from patients with testicular germ cell tumors, mesenchymal tumors and non-Hodgkin's lymphoma no genomic instability has been observed. [11] [12] [13] A familial component has been documented in a large number of tumors, such as retinoblastoma, colon, renal cell and breast carcinomas.
14 Hairy cell leukemia (HCL), a chronic lymphoproliferative disease of B cell origin, has been reported in first-degree relatives, mainly siblings, in a number of cases. [15] [16] [17] In a previous study of leukemic cells from patients with HCL we found clonal aberrations involving regions rarely involved in other hematologic tumors, ie 5q13, 2q11 and 1q42, but also abnormalities more commonly occurring in other neoplasias, ie 6q, 11p and 11q, 19q and 20q. We also noted an increase of nonclonal abnormalities. 18 Characteristically, specific aberrations could occur in various combinations in different cells, indicative of a de novo origin in single cells rather than due to clonal evolution. Specific regions were also involved in different abnormalities in single patients. Furthermore, two patients were found to have constitutional abnormalities, indicated by the presence of the aberration not only in all hairy cells but also in fibroblasts. During this investigation an increased frequency of other, sporadic abnormalities was noted in the fibroblasts.
We therefore decided to investigate non-malignant cells from HCL patients, and found an increased frequency of chromosome aberrations in skin fibroblasts from patients as compared to referents.
Patients, referents and methods
Cytogenetic analyses were performed on skin fibroblast, bone marrow and peripheral blood cells from eight patients with active disease, seven males and one female, with a median age of 51 years (range 31-73 years). At the time of sampling, only patient 9.90 had previous treatment (splenectomy, prednisolone, chlorambucil, and interferon ␣ (for details see Ref. 19) ). No other obvious occupational or other exposure of the patients to toxic agents, except that of two smokers, is known. Fibroblast chromosomes from eight healthy referents, six males and two females, with a median age of 50 years (range 28-72 years), were also investigated. One smoker and one snuff taker were included among the referents.
Cell culture
Skin biopsies were aseptically taken from the gluteal region under local anesthetic, minced and grown for one to five passages. Fibroblasts, bone marrow and blood cells were cultured as previously described 18 in RPMI 1640 supplemented with 10% fetal calf serum and, in the case of fibroblasts, penicillin and streptomycin (20 IU/ml and 20 g/ml, respectively) (Gibco, Paisley, UK). Generally, in bone marrow and blood cultures, BSF-MP6, the supernatant from a T-T hybridoma cell line (a gift of A Rosén, University Hospital, Linkö ping, Sweden), was used as a B cell mitogen. 20 In two cases, phytohemagglutinin (PHA) (Wellcome, Dartford, UK), was used as a T cell mitogen for blood lymphocytes, in one case after treatment with Dynabeads M-450 Pan B (CD19) (Dynal, Skøyen, Oslo, Norway) to remove the B cells.
The cells were harvested by the use of colchicine (Demecolcine; Sigma, St Louis, MO, USA) added to a final concentration of 0.005 or 0.05 g/ml and incubated for 1 h for bone marrow and blood cells and approximately 4 h for fibroblasts. The cells were treated with a hypotonic KCl solution (75 mmol/l) and fixed in acetic acid/methanol. The slides were then flame dried to improve metaphase spreading.
Cytogenetic and FISH analyses Q-banded 21 cells were analyzed using a Cytoscan Image Analysis System (Applied Imaging, Sunderland, UK). The putative abnormal metaphases were scored blindly by one of us (UH). Chromosome abnormalities are given and clones defined according to the ISCN 1991. 22 Gaps were not taken into account.
The chromosome 7 ␣-satellite probe, D7Z1, was obtained from Oncor, Gaithersburg, MD, USA, and the No. 5 whole chromosome painting probe from Gibco BRL, Life Technologies Ltd, Grand Island, NY, USA. Both kits were used according to the protocols of the manufacturers.
Immunocytochemical investigations
Monoclonal antibodies against the following differentiationrelated molecules were obtained from Dako, Glostrup, Denmark: anti-prolyl-4-hydroxylase (Mab 5-B-5) for fibroblasts, anti-CD20 (Mab L26) for B lymphocytes, anti-CD45RO (Mab UCHL1) for T lymphocytes, anti-HLA-DR (Mab TAL.1B5) for monocytes, B lymphocytes and hairy cells, and anti-CD103 (Mab BerAct8) for hairy cells. Anti-cytokeratin (Mab Cam 5.2) for epithelial cells was obtained from Becton Dickinson (Erembodegem, Belgium). The slides were fixed in acetone and the antigens detected using a three-step avidinbiotin alkaline phosphatase system. Secondary reagents were obtained from Dako.
Results
A pericentric inversion, inv(9)(p21-22q22) (Figure 1 ), from a 31-year-old female patient, 6.93, was recurrent in both fibro-
Figure 1
Two pairs of chromosome 9 from fibroblasts of patient 6.93; to the left a pair with two normal homologues is shown and to the right a pair with an inverted No. 9, inv(9)(p21-22q22 
Fibroblasts
To exclude the possibility of contamination by other cell types, fibroblast cultures from two patients, 2.93 and 4.93, and from referent 7, were investigated immunocytochemically (courtesy of Dr Birger Christensson, Karolinska Institute at Huddinge Hospital, Stockholm, Sweden). All cells were immunoreactive with a monoclonal antibody against the ␤ chain of prolyl-4-hydroxylase, a fibroblast-related marker. In contrast, no immunoreactive cells were seen using the monoclonal antibodies against T cells, B cells, or hairy cells, against cytokeratin or HLA-DR.
Aberration frequencies:
The frequency of abnormal metaphases (Tables 1 and 2 ), including clonal and sporadic abnormalities with each clone considered one event, was significantly higher in fibroblasts from patients than from referents (P = 0.015 one-sided, Wilcoxon rank sum test). On the other hand, the frequency of chromatid and isochromatid breaks, indicative of acute chromosome damage, was not significantly different between patients and referents (P = 0.35 one-sided, Wilcoxon rank sum test).
Clonal abnormalities:
Five of the patients showed clonal abnormalities compared with one of the referents (Tables 1  and 2 ). An extra chromosome 7 was found in 26 of the 29 fibroblast metaphases during the third passage from patient 4.93, a 73-year-old male patient. Furthermore, three centromeric signals were found in 174/200 cells from this passage by the use of a centromere-specific probe for chromosome 7. However, in cells from the previous passage, where no metaphases were obtained, FISH disclosed only 2/200 cells with three chromosome 7 centromeres. Another skin biopsy from approximately the same location was taken several months later, and in slides from the first passage of this biopsy only 8/200 cells showed additional chromosome 7 signals; six cells showed three and two cells four centromeres, numbers that could be expected from a normal disomic sample.
The only clonal abnormality in referent cells was obtained from a 72-year-old male. Eight cells lacked the Y chromosome and another three metaphases also lacked the Y and showed an extra No. 15. In addition, one cell from this referent also exhibited an extra Y chromosome, a normally occurring phenomenon in bone marrow cells from elderly males. 23, 24 Sporadic abnormalities:
Six patients and four referents showed sporadic chromosome aberrations. Four of the patients and one of the referents showed abnormalities similar to those previously found in the bone marrow of patients with active HCL, 18 ie pericentric inversions of chromosomes 5 and 19, abnormalities of 6q, a deletion of 20q (Table 1) , and an interstitial deletion 11q (Table 2) . The number of abnormal metaphases, excluding chromatid abnormalities, is given both as the total number of aberrant metaphases and as the number of 'events', where each clone is counted as one event. F, M: female, male; N, S: nonsmoker, smoker; ctb: chromatid break, csb: chromosome break. 
The number of abnormal metaphases, excluding chromatid abnormalities, is given both as the total number of aberrant metaphases and as the number of 'events', where each clone is counted as one event. b B cell abnormalities of this patient also included in Haglund et al. 18 F, M: female, male; BM: bone marrow; PB: peripheral blood; ctb: chromatid break; csb: chromosome break.
Blood and bone marrow cells from patients
Five of the patients showed clonal aberrations (Table 3) . One previously reported patient had a constitutional pericentric inversion of chromosome 5, and another two patients, 4.93 and 5.93, also had acquired chromosome 5 abnormalities. Patient 4.93 had a clone with a translocation of an additional long arm of chromosome 5, with undefined breakpoint, to a D chromosome, in all probability a No. 13. The chromosome 5 fragment was analyzed by whole chromosome painting, and the short arm appeared missing. In addition, three normal chromosomes 5 were found in one cell. Patient 5.93 showed two sporadic inversions of chromosome 5, one paracentric inv(5)(q11.2q23-31), and one pericentric, the breakpoints of which could not be exactly determined. One patient had additional material inserted into q11-21 of chromosome 2.
Discussion
In order to evaluate whether a general chromosome instability is a predisposing factor for HCL we performed this cytogenetic investigation of skin fibroblasts from HCL patients and healthy controls matched for age and smoking. We then found that the frequency of numerical and structural chromosome abnormalities was elevated in normal cells from the patients, as compared to that of referents. Approximately 30 fibroblast cells were investigated from each individual. An increased number of cells investigated might have allowed detection of a significant difference also regarding the unstable abnormalities. However, the variation between individuals is large, and therefore an increase of the number of individuals would have been of greater advantage to increase the power of the study.
Cytogenetic mosaicism with a low frequency of tumor-specific breakpoints also in normal tissues of patients has been reported earlier, such as the 13q14 deletion in sporadic and hereditary retinoblastoma, the 11p13 and 3p13-14 deletions in Wilm's tumor and renal cell carcinoma, respectively, breaks in 1q12-23 in breast cancer, and structural abnormalities of chromosome 5 in colon carcinoma. 25, 26 These breakpoints involve locations of tumor suppressor genes. 14 The chromosome regions affected by abnormalities in HCL harbor genes that could confer genetic instability through various mechanisms. HCL exhibits irregularities in the process of class-switching, 27 and a gene affecting V(D)J rejoining and DNA double-strand repair, XRCC4L, has been assigned to 5q13-14, 28 the common site for constitutional and acquired abnormalities in hairy cells according to our previous study. 18 Cell cycle regulators, eg cyclins and cyclin-dependent kinases, could also contribute to chromosome instability by dysregulation of the cell cycle checkpoints, and corresponding genes to at least three such proteins are located at 5q13: ras-GAP (GTP-activating protein), 29 the human cyclin B1 gene (CCNB1), 30 and one of two distinct loci of the MO15 gene of cdk-activating kinase, CAK. 31 The clonal inv(9)(p21-22q22) in patient 6.93 occurred both in fibroblasts and in MP6-stimulated hairy cells. Although the aberration did not occur in 100% of the cells it cannot be excluded that it was constitutional and the patient mosaic with one normal and one aberrant cell lineage. We have, however, not been able to verify this possibility. Were this the case, three out of approximately 50 cytogenetically investigated HCL patients at Huddinge Hospital would have a structural constitutional abnormality.
Band 9p21 is a site commonly affected by abnormalities in various tumors. Two tandemly linked putative tumor suppressor genes, p15
INK4b and p16 INK4a , and also the IFN gene cluster, are localised to this band. 32, 33 Band 9q22, the other breakpoint of the chromosome 9 inversion, has previously been reported to be involved in HCL, 34 in skin squamous cell carcinomas, basal cell carcinomas and multiple self-healing squamous epitheliomatas, 35 as well as in Fanconi anemia and xeroderma pigmentosum, two somatic mutational and cancerprone diseases. 36 A clone with trisomy 7 was found that developed in vitro or expanded from a minimal clone, as visualized by FISH, in cultures of fibroblasts from one patient. Conflicting results regarding trisomy 7 have previously been reported. An increased frequency of trisomy 7 in cultured malignant and non-malignant lung and kidney cells has been noted, [37] [38] [39] while no increase of trisomy 7 cells was seen in uncultured non-neoplastic lung and kidney tissues from nine patients. 40 Johansson and co-workers 41 argue that trisomy 7 may have arisen in vivo as the number of cells with trisomy 7 did not increase with time and that +7 in normal kidney cells was present before short-term culture as demonstrated by FISH, and concluded that trisomy 7 in general is not associated with malignancy. Trisomy 7 is, however, increased in epithelial tumor cells of colon carcinoma 42 and is considered to correlate with tumor progression in human prostate cancer. 43 Trisomy 7, and a stepwise increase of non-random trisomies, is also a characteristic abnormality in benign thyroid tumors. 44 Loss of the Y chromosome and trisomy 7 were the most common abnormalities noted in benign prostatic hyperplasia, 45 although the authors point out the possibility that the trisomic cells may be infiltrating lymphocytes, which may have trisomy 7. 46 In our study, however, no lymphocytes or epithelial cells contaminated the fibroblast cultures.
In conclusion, chromosomal instability preceding the development of tumors seems to be a common feature of several neoplastic disorders. Our present study indicates that such constitutional and/or acquired genetic instability may also play a role in the development of hairy cell leukemia.
